Each year, around 1.5 million ICU patients face the risk of adverse drug events (ADEs), which can be life-threatening reactions to medications. Factors contributing to this risk include complex medication regimens, high workloads for ICU staff, and human error. A solution is integrating critical care pharmacists (CCPs) into healthcare teams, as their ongoing monitoring of patients’ medications—considering health histories and current statuses—can significantly reduce ADEs. Research shows that CCP involvement can lower ADE occurrences by 70%. Dr. Andrea Sikora from the University of Colorado School of Medicine is working on enhancing these results through artificial intelligence (AI) tools designed to predict ADEs before they arise, aiding in decision-making and prevention. The discussion highlights the critical role of CCPs and the promising impact of AI in improving patient safety in intensive care settings.
Source link
Share
Read more